A
20-year-old female presents with recurrent episodes of central chest pain that
are non-exertional, sudden in onset, and last approximately 5 to 15 minutes.
The pain is substernal and severe, radiates to the left arm, jaw, and neck, and
is associated with nausea and diaphoresis. She has a history of Raynaud
disease. Vital signs are normal between episodes. Electrocardiography during an
ergonovine provocation test demonstrates transient ST-segment elevation.
Coronary angiography demonstrates coronary vasospasm without significant
obstructive atherosclerotic disease. Diagnosis?
Diagnosis is Prinzmetal (variant) angina, a
classic form of vasospastic angina.
1. Definition
Prinzmetal angina, also called variant angina, is a
classic form of vasospastic angina caused by transient
constriction of an epicardial coronary artery, producing a dynamic reduction in
coronary blood flow and transient myocardial ischemia.
Classic Prinzmetal angina is characterized by
episodes of angina, usually occurring at rest, accompanied by transient
ST-segment elevation.
Vasospastic angina may occur in patients with
normal or near-normal coronary arteries, but the presence of
coexisting coronary atherosclerosis does not exclude the diagnosis.
2. Etiology and Predisposing Factors
The underlying mechanism is abnormal coronary
vasomotor reactivity. Important mechanisms and associated factors include:
1.
Hyperreactivity
of coronary vascular smooth muscle
2.
Endothelial
dysfunction
3.
Autonomic
and vasomotor abnormalities
4.
Cigarette
smoking
o
An important
modifiable risk factor for coronary vasospasm
5.
Vasoconstrictive
substances or drugs
o
Cocaine
o
Amphetamines and
other sympathomimetics
o
Ergot derivatives
o
Other
vasoconstrictive medications
6.
Potential
precipitating factors
o
Cold exposure
o
Emotional stress
o
Hyperventilation
o
Alcohol in
susceptible individuals
7.
Associated
vasomotor disorders
o
Raynaud disease
o
Migraine
These associations may support a tendency
toward abnormal vasomotor reactivity but are not diagnostic of
vasospastic angina.
3. Pathophysiology
1.
A coronary artery
undergoes transient intense vasoconstriction.
2.
The vasospasm
causes a marked temporary reduction in the coronary arterial lumen.
3.
Coronary blood
flow decreases, producing transient myocardial ischemia.
4.
Severe epicardial
coronary spasm may produce transient myocardial ischemia with
ST-segment elevation.
5.
When the
vasospasm resolves spontaneously or after administration of a vasodilator such
as a nitrate, coronary blood flow is restored and the ECG changes typically
resolve.
6.
Prolonged or
severe vasospasm can cause:
o
Myocardial
infarction
o
Ventricular
arrhythmias
o
Bradyarrhythmias
o
Sudden cardiac
death
4. Clinical Features
4.1 Core Features
1.
Angina
occurring predominantly at rest
2.
Sudden
onset of chest pain
3.
Episodes often
occur in a circadian pattern, particularly at night or in the
early morning
4.
Exercise
tolerance may be relatively preserved
5.
Episodes are
usually brief but may recur in clusters
6.
Symptoms
generally respond rapidly to short-acting nitrates
Although rest angina is characteristic,
vasospastic angina is not absolutely restricted to rest and can occasionally
occur during exertion.
4.2 Associated Features
During an episode, patients may experience:
1.
Diaphoresis
2.
Nausea
3.
Palpitations
4.
Presyncope
or syncope if significant
arrhythmia occurs
5.
Radiation of pain
to the arm, shoulder, jaw, neck, or back
A history of a vasomotor disorder such as Raynaud
disease may increase clinical suspicion but does not establish the
diagnosis.
5. Diagnosis
The diagnosis is based on the characteristic
clinical presentation together with documentation of transient myocardial
ischemia or coronary artery spasm.
5.1 Electrocardiography
During an episode, the ECG may demonstrate:
1.
Transient
ST-segment elevation
2.
Transient
ST-segment depression
3.
Other transient
ischemic changes
In classic Prinzmetal or variant angina, transient
ST-segment elevation is characteristic.
The ECG may return completely to baseline
after the vasospasm resolves.
5.2 Cardiac Biomarkers
1.
Cardiac
biomarkers are often normal after brief episodes of reversible
ischemia.
2.
Troponin may
become elevated when vasospasm is prolonged or sufficiently severe to
cause myocardial injury or infarction.
5.3 Coronary Angiography
Coronary angiography may show:
1.
No
significant obstructive coronary artery disease
2.
Transient
epicardial coronary vasospasm
3.
Resolution of the
spasm after administration of an intracoronary nitrate
Vasospastic angina can also occur in patients
with coexisting atherosclerotic coronary disease. Therefore, normal coronary
arteries are not required for the diagnosis.
5.4 Provocation Testing
When spontaneous episodes have not been
adequately documented, coronary vasospasm may be assessed during invasive
coronary angiography using pharmacologic provocation.
Common provocative agents include:
1.
Acetylcholine
2.
Ergonovine
A positive test for epicardial coronary
vasospasm typically requires:
1.
Reproduction of
the patient's characteristic chest pain
2.
Ischemic
ECG changes
3.
Severe
transient epicardial coronary constriction
Severe epicardial coronary vasospasm is
generally defined by approximately 90% or greater angiographic
constriction together with characteristic symptoms and ischemic ECG
changes.
Contemporary ESC criteria use at
least 90% reduction in coronary lumen diameter, COVADIS
criteria use greater than 90% constriction, and JCS criteria
specify greater than 90% focal stenosis or 90% diffuse vasoconstriction
involving at least two contiguous coronary segments.
Provocation testing should be performed in an
appropriately equipped cardiac catheterization laboratory by experienced
clinicians because significant bradyarrhythmias, ventricular arrhythmias, or
prolonged vasospasm can occur.
In this patient, transient ST-segment
elevation during provocation together with angiographically demonstrated
coronary vasospasm strongly supports the diagnosis.
6. Management
6.1 Acute Treatment
Short-acting nitrates are used for rapid relief of an acute vasospastic
episode.
Examples include:
1.
Sublingual
nitroglycerin
2.
Sublingual
or other rapidly acting nitrate preparations
Nitrates relax coronary vascular smooth
muscle and usually relieve the vasospasm rapidly.
6.2 Long-Term Prevention
Calcium channel blockers are the
first-line preventive treatment for vasospastic angina.
Examples include:
1.
Diltiazem
2.
Verapamil
3.
Amlodipine
4.
Nifedipine
In patients with severe or persistent
vasospastic angina, higher doses or a combination of a dihydropyridine
and non-dihydropyridine calcium channel blocker may be required under
appropriate clinical supervision.
6.3 Nitrates for Prevention
Long-acting nitrates may be added when symptoms remain inadequately
controlled with calcium channel blockers.
They are generally used as adjunctive
therapy rather than as the sole first-line preventive treatment.
6.4 Risk Factor and Trigger Modification
Patients should be advised to:
1.
Stop
smoking
2.
Avoid cocaine
and other sympathomimetic recreational drugs
3.
Avoid medications
or substances known to precipitate coronary vasospasm when possible
4.
Manage
conventional cardiovascular risk factors when present
6.5 Beta Blockers
Beta blockers are generally avoided
in isolated vasospastic angina, particularly agents without alpha-1 adrenergic
blocking activity, because they
may exacerbate coronary vasospasm in susceptible patients.
This is particularly relevant to nonselective
beta blockers.
If a beta blocker is required for another
compelling indication, treatment should be individualized rather than considering
all beta blockers absolutely contraindicated.
7. Complications
Vasospastic angina can occasionally produce
serious complications, particularly when vasospasm is prolonged or involves a
major coronary artery.
Complications include:
1.
Ventricular
tachycardia or ventricular fibrillation
2.
Bradyarrhythmias
or atrioventricular block
3.
Syncope
4.
Myocardial
infarction
5.
Sudden
cardiac death
8. Key Clinical Insight
Rest angina + transient ST-segment
elevation + angiographically demonstrated reversible coronary vasospasm
strongly indicates Prinzmetal or variant angina.
In this patient, the combination of recurrent
non-exertional chest pain, transient ST-segment elevation during pharmacologic
provocation, and angiographically demonstrated coronary vasospasm without
significant obstructive coronary disease establishes the diagnosis of Prinzmetal
(variant) angina, a classic form of vasospastic angina.
Her history of Raynaud disease
provides an additional clue to abnormal vasomotor reactivity but is not itself
diagnostic.
References
1.
Vrints C,
Andreotti F, Koskinas KC, et al. 2024 ESC Guidelines for the management of
chronic coronary syndromes. European Heart Journal. 2024;45(36):3415-3537.
doi:10.1093/eurheartj/ehae177.
2.
Hokimoto S,
Kaikita K, Yasuda S, et al. JCS/CVIT/JCC 2023 Guideline Focused Update on
Diagnosis and Treatment of Vasospastic Angina (Coronary Spastic Angina) and
Coronary Microvascular Dysfunction. Circulation Journal.
2023;87(6):879-936. doi:10.1253/circj.CJ-22-0779.
3. Beltrame JF, Crea F, Kaski JC, et al. International standardization of diagnostic criteria for vasospastic angina. European Heart Journal. 2017;38(33):2565-2568. doi:10.1093/eurheartj/ehv351.
No comments:
Post a Comment